secwatch.observer — SEC 8-K summary
======================================

Issuer:     Charlotte's Web Holdings, Inc. (CWBHF)
CIK:        0001750155
Form:       8-K
Filed at:   2026-03-31T23:59:59+00:00
Accession:  0001750155-26-000028
Event type: earnings
Sentiment:  neutral
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Charlotte's Web Q4 rev $13.3M (+4.7% YoY), net loss $11.5M; announces BAT debenture conversion & CMMI pilot
--------------------------------------------------------------------------------

- Q4 2025 revenue $13.3M, up 4.7% YoY; net loss $11.5M ($0.07 loss per share).
- Full-year 2025 revenue $49.9M (+0.5% YoY); net loss $29.7M ($0.19 per share).
- BAT to convert C$75.3M debenture + $10M new equity, holding ~40% of shares; subject to TSX and shareholder approval.
- Charlotte's Web selected as CBD launch partner for CMMI Medicare pilot; CMS BEI guidance allows up to $500/beneficiary annually starting April 2026.
- DeFloria (33% owned) cleared by FDA for Phase 2 trial of AJA001 for autism irritability; expects mid-2026 start.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750155/000175015526000028/0001750155-26-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750155/000175015526000028/cweb-20260331.htm
  HTML page:      https://secwatch.observer/filing/0001750155-26-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer